Positron emission tomography imaging in dementia
The lawsuits name pharmaceutical companies responsible for manufacturing and marketing GLP-1 medications without adequate warnings: Novo Nordisk, the maker of Ozempic (for type 2 diabetes), Wegovy (for weight loss), and Rybelsus (oral semaglutide for diabetes) Eli Lilly, the maker of Trulicity (dulaglutide) and Mounjaro (tirzepatide), which are also GLP-1 receptor agonists associated with similar gastrointestinal risks These companies marketed their products heavily, particularly for weight loss, without fully disclosing the potential for severe and potentially permanent digestive complications
For example, magnesium L-threonate is studied for healthy cognitive function, magnesium acetyl taurinate is intended for stress management, and magnesium carbonate can help fight occasional constipation
Its antibacterial properties also aid in fighting skin infections, making it a must-have for clear and radiant skin
As of early 2026, over 3,000 lawsuits are pending against the manufacturers of GLP-1 drugs
Wegovy is ideally taken on the same day each week